Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-11-05FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental NDA for Protonix IV (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer), confirming/adding the intrave…
-
FDA approval · 2014-10-31FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole from Sandoz Inc, authorizing continued manufacture and sale of a generic omeprazole p…
-
FDA approval · 2014-10-31FDA Approved: OMEPRAZOLE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's generic omeprazole, establishing bioequivalence to the reference product and authorizing its marketing in the United…
-
CLINICAL_TRIALS research · 2014-10-29Clinical Trial Update: The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate [Phase 4]
Phase 4 clinical trial update investigating the relationship between gastroesophageal reflux disease and pediatric rhinitis, noting the sign…
-
FDA label_change · 2014-10-15FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC to update the labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-10-03FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental NDA for NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) by Haleon US Holdings LLC.
-
CLINICAL_TRIALS research · 2014-10-03Clinical Trial Update: Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt
A completed AstraZeneca-sponsored clinical trial (NCT01635959) investigates the prevalence of gastroesophageal reflux disease (GERD) among p…
-
FDA approval · 2014-09-26FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approves a supplemental application for PROTONIX I.V., authorizing the intravenous form of pantoprazole sodium.
-
FDA approval · 2014-09-26FDA Approved: TAGAMET — Supplemental Application (Prestige Brands Holdings, Inc.)
The FDA approved a supplemental application for Tagamet (cimetidine) filed by Prestige Brands Holdings, Inc., likely resulting in labeling c…
-
CLINICAL_TRIALS research · 2014-09-12Clinical Trial Update: RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol
This document provides an update on the preliminary study protocol for RESULT, a trial evaluating reflux surgery in lung transplant recipien…
-
FDA approval · 2014-09-10FDA Approved: PANTOPRAZOLE SODIUM — Original Application (XLCare Pharmaceuticals Inc.)
FDA approves the original abbreviated new drug application for pantoprazole sodium, enabling a generic pantoprazole product from XLCare Phar…
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn [Phase 3]
Phase 3 trial evaluating the efficacy of imipramine for esophageal hypersensitivity and functional heartburn in patients with gastroesophage…
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating pain modulation strategies for gastroesophageal reflux disease in patients who failed standard-dose pr…
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis [Phase 2]
This update reports the completion of a Phase 2 trial evaluating CJ-12420 for erosive esophagitis and gastroesophageal reflux disease.
-
CLINICAL_TRIALS research · 2014-08-07Clinical Trial Update: An Investigation of Electrical Stimulation on Gastroesophageal Reflux Disease (GERD) in Patients After Sleeve Gastrectomy [NA]
This is an update on a clinical trial evaluating electrical stimulation as a treatment for gastroesophageal reflux disease in patients who h…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents [Phase 2]
Phase 2 trial assessing the safety and efficacy of Dexlansoprazole delayed-release capsules for symptomatic non-erosive gastroesophageal ref…
-
FDA approval · 2014-08-05FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for pantoprazole sodium by Lannett Company, Inc. under an ANDA.
-
CLINICAL_TRIALS research · 2014-08-05Clinical Trial Update: Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE. [Phase 1, Phase 2]
Clinical trial update comparing Nexium (esomeprazole) versus Secretol for healing and symptom control in GERD patients with erosive esophagi…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers [Phase 1]
A Phase 1 trial by Ono Pharmaceutical evaluating ONO-8539 for acid-induced esophageal hypersensitivity in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Diagnostic of Transient Lower Esophageal Sphincter Relaxation With Combined Impedance and High Resolution Manometry in Patients With GERD [NA]
Completion of a clinical trial evaluating the diagnostic accuracy of combining impedance monitoring with high-resolution manometry to detect…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI [Phase 2]
Phase 2 trial assessing the safety and efficacy of AST-120 in GERD patients who remain symptomatic on standard-dose proton pump inhibitors w…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma [Phase 2]
Phase 2 study evaluating esomeprazole magnesium (Nexium) for potential anti-asthmatic effects in asthma with GERD. Results were posted on 20…
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Phase 3/Safety & Efficacy of Esomeprazole in Infants [Phase 3]
Phase 3 trial results for esomeprazole in infants evaluating safety and efficacy for gastroesophageal reflux disease.
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter [NA]
Observational feasibility study of the Magnetic Esophageal Sphincter for gastroesophageal reflux disease has completed with results posted.
-
FDA approval · 2014-05-30FDA Approved: FAMOTIDINE — Original Application (Akorn)
The FDA approved Akorn's original application for a generic famotidine product, enabling market entry of a competitor to the brand-name drug…